Medicinska fakulteten

Organisation: fakultet

Fler filtreringsmöjligheter
  1. Diamond Blackfan anemia is mediated by hyperactive Nemo-like kinase

    M. C. Wilkes, K. Siva, J. Chen, G. Varetti, M. Y. Youn, H. Chae, F. Ek, R. Olsson, T. Lundbäck, D. P. Dever, T. Nishimura, A. Narla, B. Glader, H. Nakauchi, M. H. Porteus, C. E. Repellin, H. T. Gazda, S. Lin, M. Serrano, J. Flygare & 1 andra, K. M. Sakamoto, 2020, I: Nature Communications. 11, 1, 3344.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Metformin-induced suppression of Nemo-like kinase improves erythropoiesis in preclinical models of Diamond–Blackfan anemia through induction of miR-26a

    Mark C. Wilkes, Kavitha Siva, Gianluca Varetti, Jacqueline Mercado, Ethan P. Wentworth, Cristina A. Perez, Mallika Saxena, Sharon Kam, Simryn Kapur, Jun Chen, Anu Narla, Bert Glader, Shou Lin, Manuel Serrano, Johan Flygare & Kathleen M. Sakamoto, 2020 nov 1, I: Experimental Hematology. 91, s. 65-77 13 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy

    N. Wilking, E. Lidbrink, T. Wiklund, B. Erikstein, H. Lindman, Per Malmström, P. Kellokumpu-Lehtinen, N. -O. Bengtsson, G. Soederlund, G. Anker, E. Wist, S. Ottosson, E. Salminen, P. Ljungman, H. Holte, J. Nilsson, C. Blomqvist & J. Bergh, 2007, I: Annals of Oncology. 18, 4, s. 694-700

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales

    C P Wilkinson, Frederick L 3rd Ferris, Ronald E Klein, Paul P Lee, Carl-David Agardh, Matthew Davis, Diana Dills, Anselm Kampik, R Pararajasegaram & Juan T Verdaguer, 2003, I: Ophthalmology. 110, 9, s. 1677-1682

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Monitoring levels of preservative sensitivity in Europe - A 10-year overview (1991-2000)

    JD Wilkinson, S Shaw, KE Andersen, FM Brandao, DP Bruynzeel, Magnus Bruze, JMG Camarasa, TL Diepgen, G Ducombs, PJ Frosch, A Goossens, JM Lachappelle, A Lahti, T Menne, S Seidenari, A Tosti & JE Wahlberg, 2002, I: Contact Dermatitis. 46, 4, s. 207-210

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. The European baseline series and recommended additions: 2019

    Mark Wilkinson, Margarida Gonçalo, Olivier Aerts, Sonia Badulici, Niels H. Bennike, Dirk Bruynzeel, Heinrich Dickel, Jose L. Garcia-Abujeta, Ana M. Giménez-Arnau, Curt Hamman, Marléne Isaksson, Jeanne D. Johansen, Vera Mahler, Bo Niklasson, David Orton, Paolo Pigatto, Gyorgyi Ponyai, Thomas Rustemeyer, Marie L.A. Schuttelaar, Radoslaw Spiewak & 2 andra, Jacob P. Thyssen & Wolfgang Uter, 2019, I: Contact Dermatitis. 80, 1, s. 1-4

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia

    Kerstin Willander, Jonas Ungerback, Karin Karlsson, Mats Fredrikson, Peter Soderkvist & Mats Linderholm, 2010, I: European Journal of Haematology. 85, 3, s. 251-256

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients

    Kerstin Willander, Ravi Kumar Dutta, Jonas Ungerback, Rebeqa Gunnarsson, Gunnar Juliusson, Mats Fredrikson, Mats Linderholm & Peter Soderkvist, 2013, I: BMC Cancer. 13, 274.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness

    Sara M Willems, Daniel J. Wright, Felix R Day, Katerina Trajanoska, Peter K. Joshi, John A. Morris, Amy M. Matteini, Fleur C. Garton, Niels Grarup, Nikolay Oskolkov, Anbupalam Thalamuthu, Massimo Mangino, Jun Liu, Ayse Demirkan, Monkol Lek, Liwen Xu, Guan Wang, Christopher Oldmeadow, Kyle J Gaulton, Luca A. Lotta & 31 andra, Eri Miyamoto-Mikami, Manuel A. Rivas, Tom White, Po Ru Loh, Mette Aadahl, Najaf Amin, John R Attia, Krista Austin, Beben Benyamin, Søren Brage, Yu Ching Cheng, Paweł Ciȩszczyk, Wim Derave, Karl Fredrik Eriksson, Nir Eynon, Allan Linneberg, Alejandro Lucia, Myosotis Massidda, Braxton D. Mitchell, Motohiko Miyachi, Haruka Murakami, Sandosh Padmanabhan, Ashutosh Pandey, Ioannis Papadimitriou, Deepak K. Rajpal, Craig Sale, Cecilia M. Lindgren, Paul W. Franks, Ola Hansson, Thorvaldur Ingvarsson & GEFOS Anytype of Fracture Consortium GEFOS Anytype of Fracture Consortium, 2017 jul 12, I: Nature Communications. 8, 16015.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Similarity of uterine mucosa changes in patients treated by Raloxifen and Tamoxifen

    R Willen, H Willlen & Bengt Lindahl, 2002, I: Anticancer research. 22, 2B, s. 1121-1125

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix

    R Willen, A Himmelmann, Eva Långström-Einarsson, Mårten Fernö, Jonas Ranstam, Bo Baldetorp, J Skjaerris, J Prien-Larsen, C Trope & U Stendahl, 1993, I: Anticancer research. 13, 4, s. 1187-1196

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Aβ accumulation causes MVB enlargement and is modelled by dominant negative VPS4A

    Katarina Willén, James R Edgar, Takafumi Hasegawa, Nobuyuki Tanaka, Clare E Futter & Gunnar K Gouras, 2017, I: Molecular Neurodegeneration. 12, 61.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses

    Katarina Willén, Agnieszka Sroka, Reisuke H. Takahashi & Gunnar K. Gouras, 2017, I: Journal of Alzheimer's Disease. 60, 2, s. 511-524 14 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Involvement of endosomal and synaptic Aβ in models of Alzheimer's disease.

    Katarina Willén, 2017, Lund: Lund University: Faculty of Medicine. 80 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  15. Safety and efficacy of valsartan versus enalapril in heart failure patients.

    Ronnie Willenheimer, Claes Helmers, Emil Pantev, Erik Rydberg, Per Löfdahl & Allan Gordon, 2002, I: International Journal of Cardiology. 85, 2-3, s. 261-270

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Treatment of early heart failure: an ACEI or a beta-blocker first?

    Ronnie Willenheimer, 2006, I: Expert Opinion on Investigational Drugs. 15, 5, s. 487-493

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  17. Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.

    Ronnie Willenheimer, Erland Erdmann, Ferenc Follath, Henry Krum, Piotr Ponikowski, Bernard Silke, Dirk J Van Veldhuisen, Louis Van De Ven, Patricia Verkenne & Philippe Lechat, 2004, I: European Journal of Heart Failure. 6, 4, s. 493-500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure

    Ronnie Willenheimer, DJ van Veldhuisen, P Ponikowski & P Lechat, 2005, I: Journal of the American College of Cardiology. 46, 1, s. 182-182

    Forskningsoutput: TidskriftsbidragLetter

  19. Echocardiographic assessment of left atrioventricular plane displacement as a complement to left ventricular regional wall motion evaluation in the detection of myocardial dysfunction.

    Ronnie Willenheimer, Erik Rydberg, Martin Stagmo, Petri Gudmundsson, Gerd Ericsson & Leif RW Erhardt, 2002, I: International Journal of Cardiovascular Imaging. 18, 3, s. 181-186

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Comment on "Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS-III, by JGF Cleland and others".

    Ronnie Willenheimer, Henry Krum, Dirk J van Veldhuisen, Christian Funck-Brentano, Erland Erdmann & Wilfried R Meyer, 2006, I: European Journal of Heart Failure. 8, 2, s. 219-220

    Forskningsoutput: TidskriftsbidragLetter

  21. Implications of CIBIS III: a commentary.

    Ronnie Willenheimer, 2005, I: Journal of the Renin-Angiotensin-Aldosterone System. 6, 3, s. 115-120

    Forskningsoutput: TidskriftsbidragLetter

  22. The current role of beta-blockers in chronic heart failure: with special emphasis on the CIBIS III trial

    Ronnie Willenheimer, 2009, I: European Heart Journal Supplements. 11, A, s. A15-A20

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Chairmen's Foreword: beta-blockade across the cardiovascular continuum-when and where to use?

    Ronnie Willenheimer & Erland Erdmann, 2009, I: European Heart Journal Supplements. 11, A, s. A1-A2

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  24. Effect on Survival and Hospitalization of Initiating Treatment for Chronic Heart Failure With Bisoprolol Followed by Enalapril, as Compared With the Opposite Sequence. Results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.

    Ronnie Willenheimer, Dirk J van Veldhuisen, Bernard Silke, Erland Erdmann, Ferenc Follath, Henry Krum, Piotr Ponikowski, Allan Skene, Louis van de Ven, Patricia Verkenne & Philippe Lechat, 2005, I: Circulation. 112, 16, s. 2426-2435

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift